Article(id=1329876018963264182, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329875988802023702, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.10.006, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1706198400000, receivedDateStr=2024-01-26, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794996750822, onlineDateStr=2026-11-18, pubDate=1728489600000, pubDateStr=2024-10-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794996750822, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794996750822, creator=13701087609, updateTime=1794996750822, updator=13701087609, issue=Issue{id=1329875988802023702, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='10', pageStart='1307', pageEnd='1448', issueExtLink='null', onlineDate='null', pubDate='1728489600000', pubDateStr='2024-10-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794996743631, creator='13701087609', updateTime=1794996743631, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext=null, issueFiles=null, downloadFileDto=null}, startPage=1350, endPage=1358, ext={EN=ArticleExt(id=1329876019164590775, articleId=1329876018963264182, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Patent Layout and Analysis of Atezolizumab, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Atezolizumab, as a new PD-L1 inhibitor drug, has become one of the hot spots in tumor immunotherapy research. This review takes atezolizumab as the research object, uses patent technology analysis to study the status of related patent applications, and focuses on the patent applications of atezolizumab in China from the perspective of its technical themes and patent layout, so as to provide some effective references and suggestions for domestic research institutions and enterprises in R&D and patent layout strategies of atezolizumab.

, authors=Tian ZHAO1, Zicai LI2, Lu HUANG3, 4, 5, *, authorsList=Tian ZHAO, Zicai LI, Lu HUANG, authorCompany=null, correspAuthors=Lu HUANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329876019495940792, articleId=1329876018963264182, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=阿替利珠单抗的专利布局及分析, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

阿替利珠单抗作为一种新的PD-L1抑制剂药物,已成为肿瘤免疫治疗研究的热点之一。文章以阿替利珠单抗为研究对象,利用专利技术分析其相关专利申请状况,并重点从其技术主题和专利布局角度对阿替利珠单抗在中国的专利申请情况进行剖析,从而为国内研究机构和企业进行该药物研发和专利布局策略提供有效的参考和建议。

, authors=赵天1, 李自财2, 黄璐3, 4, 5, *, authorsList=赵天, 李自财, 黄璐, authorCompany=null, correspAuthors=黄璐, authorNote=

赵天(1986—),男,硕士,助理研究员,从事科研管理、知识产权管理以及科技成果转化工作。

, correspAuthorsNote=
黄璐(1982—),男,博士,高级工程师,硕士生导师,从事药品与医疗器械开发以及生物医药知识产权工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=GYhp62WIHPDY9xT5i6Kriw==, magXml=/Uf9NR8FREa/mAIDZcs0AA==, pdfUrl=null, pdf=In1aa9QiMmw7XvOQEZtOwA==, pdfFileSize=3738043, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=SXNu/JnmGzX0I/7B0OPQgg==, mapNumber=null, fund=null)}, authors=[Author(id=1329876020167029449, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329876020297052875, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020167029449, language=EN, stringName=Tian ZHAO, firstName=Tian, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Guangdong Provincial Biotechnology Research Institute (Guangdong Provincial Laboratory Animals Monitoring Center), Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329876020422881996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020167029449, language=CN, stringName=赵天, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663, bio={"content":"

赵天(1986—),男,硕士,助理研究员,从事科研管理、知识产权管理以及科技成果转化工作。

"}, bioImg=null, bioContent=

赵天(1986—),男,硕士,助理研究员,从事科研管理、知识产权管理以及科技成果转化工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329876019714044601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=1., ext=[AuthorCompanyExt(id=1329876019726627514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019714044601, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Guangdong Provincial Biotechnology Research Institute (Guangdong Provincial Laboratory Animals Monitoring Center), Guangzhou 510663), AuthorCompanyExt(id=1329876019735016123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019714044601, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663)])]), Author(id=1329876020494185166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329876020565488336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020494185166, language=EN, stringName=Zicai LI, firstName=Zicai, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.HIMMUC Information Technology (Guangzhou) Co., Ltd., Guangzhou 510670, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329876020628402897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020494185166, language=CN, stringName=李自财, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.天启黑马信息科技(广州)有限公司,广东 广州 510670, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329876019793736380, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=2., ext=[AuthorCompanyExt(id=1329876019802124989, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019793736380, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.HIMMUC Information Technology (Guangzhou) Co., Ltd., Guangzhou 510670), AuthorCompanyExt(id=1329876019810513598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019793736380, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.天启黑马信息科技(广州)有限公司,广东 广州 510670)])]), Author(id=1329876020720677587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=47153437@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329876020817146583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020720677587, language=EN, stringName=Lu HUANG, firstName=Lu, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, 5, *, address=3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430072
4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205
5.Guangzhou BioBlue Technology Co., Ltd., Guangzhou 510200, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329876020888449752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020720677587, language=CN, stringName=黄璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, 5, *, address=3.武汉大学药学院,湖北 武汉 430072
4.武汉工程大学化工与制药学院,湖北 武汉 430205
5.广州市丹蓝生物科技有限公司,广东 广州 510200, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329876019881816767, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=3., ext=[AuthorCompanyExt(id=1329876019890205376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019881816767, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430072), AuthorCompanyExt(id=1329876019894399681, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019881816767, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.武汉大学药学院,湖北 武汉 430072)]), AuthorCompany(id=1329876019948925634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=4., ext=[AuthorCompanyExt(id=1329876019961508547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019948925634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205), AuthorCompanyExt(id=1329876019969897156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019948925634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.武汉工程大学化工与制药学院,湖北 武汉 430205)]), AuthorCompany(id=1329876020045394629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=5., ext=[AuthorCompanyExt(id=1329876020053783238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876020045394629, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=5.Guangzhou BioBlue Technology Co., Ltd., Guangzhou 510200), AuthorCompanyExt(id=1329876020066366151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876020045394629, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=5.广州市丹蓝生物科技有限公司,广东 广州 510200)])])], keywords=[Keyword(id=1329876020984918745, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=EN, orderNo=1, keyword=atezolizumab), Keyword(id=1329876021039444698, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=EN, orderNo=2, keyword=PD-L1 inhibitor), Keyword(id=1329876021106553563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=EN, orderNo=3, keyword=tumor immunotherapy), Keyword(id=1329876021173662428, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=EN, orderNo=4, keyword=patent technology analysis), Keyword(id=1329876021236576989, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=EN, orderNo=5, keyword=patent layout), Keyword(id=1329876021295297246, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=CN, orderNo=1, keyword=阿替利珠单抗), Keyword(id=1329876021362406111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=CN, orderNo=2, keyword=PD-L1抑制剂), Keyword(id=1329876021471458016, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=CN, orderNo=3, keyword=肿瘤免疫治疗), Keyword(id=1329876021546955489, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=CN, orderNo=4, keyword=专利技术分析), Keyword(id=1329876021614064354, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, language=CN, orderNo=5, keyword=专利布局)], refs=[Reference(id=1329876021827973860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=HODI F S, O’DAY S J, MCDERMOTT D F, et al.Improved survival with ipilimumab in patients with metastatic melanoma[J].N Engl J Med, 2010, 363(8): 711-723., articleTitle=null, refAbstract=null), Reference(id=1329876021916054245, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=RIBAS A, WOLCHOK J D.Cancer immunotherapy using checkpoint blockade [J].Science, 2018, 359(6382): 1350-1355., articleTitle=null, refAbstract=null), Reference(id=1329876022008328934, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=YI M, ZHENG X, NIU M, et al.Combination strategies with PD-1/PD-L1 blockade: current advances and future directions[J].Mol Cancer, 2022, 21(1): 28., articleTitle=null, refAbstract=null), Reference(id=1329876022075437799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=GONG J, LE T Q, MASSARELLI E, et al. Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination [J].J Immunother Cancer, 2018, 6(1): 46., articleTitle=null, refAbstract=null), Reference(id=1329876022142546664, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Atezolizumab for urothelial carcinoma [EB/OL].(2016-05-19) [2024-03-01].https://www.fda.gov/drugs/resources-information-approved-drugs/atezolizumab-urothelial-carcinoma., articleTitle=null, refAbstract=null), Reference(id=1329876022234821353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=INMAN B A, LONGO T A, RAMALINGAM S, et al.Atezolizumab: a PD-L1-blocking antibody for bladder cancer[J].Clin Cancer Res, 2017, 23(8): 1886-1890., articleTitle=null, refAbstract=null), Reference(id=1329876022310318826, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=HERBST R S, GIACCONE G, DE MARINIS F, et al.Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC [J].N Engl J Med, 2020, 383(14): 1328-1339., articleTitle=null, refAbstract=null), Reference(id=1329876022385816299, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHMID P, ADAMS S, RUGO H S, et al.Atezolizumab and Nab-paclitaxel in advanced triple-negative breast cancer [J].N Engl J Med, 2018, 379(22): 2108-2121., articleTitle=null, refAbstract=null), Reference(id=1329876022469702380, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=MITTENDORF E A, ZHANG H, BARRIOS C H, et al.Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer(IMpassion031): a randomised, double-blind, phase 3 trial [J].Lancet, 2020, 396(10257): 1090-1100., articleTitle=null, refAbstract=null), Reference(id=1329876022541005549, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE M S, RYOO B Y, HSU C H, et al.Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma(GO30140): an open-label, multicentre, phase 1b study [J].Lancet Oncol, 2020, 21(6): 808-820., articleTitle=null, refAbstract=null), Reference(id=1329876022616503022, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=刘建,黄璐.中国医药企业知识产权管理[M].北京:知识产权出版社,2021., articleTitle=null, refAbstract=null), Reference(id=1329876022683611887, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=葛凡,孙建,黄璐.小分子周期蛋白依赖性激酶4/6抑制剂药物及其专利研究[J].中国医药工业杂志,2022,53(4):464-473., articleTitle=null, refAbstract=null), Reference(id=1329876022754915056, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=黄璐,钱丽娜,张晓瑜,等.医药领域的专利保护与专利布局策略[J].中国新药杂志,2017,26(2):139-144., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329876021718921955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, awardId=18BFX168, language=CN, fundingSource=国家社会科学基金项目——“专利到期药物仿制上市法律保障机制研究”(18BFX168), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329876019714044601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=1., ext=[AuthorCompanyExt(id=1329876019726627514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019714044601, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Guangdong Provincial Biotechnology Research Institute (Guangdong Provincial Laboratory Animals Monitoring Center), Guangzhou 510663), AuthorCompanyExt(id=1329876019735016123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019714044601, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663)]), AuthorCompany(id=1329876019793736380, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=2., ext=[AuthorCompanyExt(id=1329876019802124989, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019793736380, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.HIMMUC Information Technology (Guangzhou) Co., Ltd., Guangzhou 510670), AuthorCompanyExt(id=1329876019810513598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019793736380, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.天启黑马信息科技(广州)有限公司,广东 广州 510670)]), AuthorCompany(id=1329876019881816767, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=3., ext=[AuthorCompanyExt(id=1329876019890205376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019881816767, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430072), AuthorCompanyExt(id=1329876019894399681, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019881816767, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.武汉大学药学院,湖北 武汉 430072)]), AuthorCompany(id=1329876019948925634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=4., ext=[AuthorCompanyExt(id=1329876019961508547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019948925634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205), AuthorCompanyExt(id=1329876019969897156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019948925634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.武汉工程大学化工与制药学院,湖北 武汉 430205)]), AuthorCompany(id=1329876020045394629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=5., ext=[AuthorCompanyExt(id=1329876020053783238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876020045394629, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=5.Guangzhou BioBlue Technology Co., Ltd., Guangzhou 510200), AuthorCompanyExt(id=1329876020066366151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876020045394629, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=5.广州市丹蓝生物科技有限公司,广东 广州 510200)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.10.006, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.10.006, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.10.006, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.10.006, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1728489600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
阿替利珠单抗的专利布局及分析
赵天 1 , 李自财 2 , 黄璐 3, 4, 5, *
中国医药工业杂志 | 综述 2024,55(10): 1350-1358
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (10) : 1350 -1358
阿替利珠单抗的专利布局及分析
全屏
[Author(id=1329876020167029449, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329876020297052875, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020167029449, language=EN, stringName=Tian ZHAO, firstName=Tian, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Guangdong Provincial Biotechnology Research Institute (Guangdong Provincial Laboratory Animals Monitoring Center), Guangzhou 510663, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329876020422881996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020167029449, language=CN, stringName=赵天, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663, bio={"content":"

赵天(1986—),男,硕士,助理研究员,从事科研管理、知识产权管理以及科技成果转化工作。

"}, bioImg=null, bioContent=

赵天(1986—),男,硕士,助理研究员,从事科研管理、知识产权管理以及科技成果转化工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329876019714044601, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=1., ext=[AuthorCompanyExt(id=1329876019726627514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019714044601, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Guangdong Provincial Biotechnology Research Institute (Guangdong Provincial Laboratory Animals Monitoring Center), Guangzhou 510663), AuthorCompanyExt(id=1329876019735016123, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019714044601, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663)])]), Author(id=1329876020494185166, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329876020565488336, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020494185166, language=EN, stringName=Zicai LI, firstName=Zicai, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.HIMMUC Information Technology (Guangzhou) Co., Ltd., Guangzhou 510670, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329876020628402897, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020494185166, language=CN, stringName=李自财, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.天启黑马信息科技(广州)有限公司,广东 广州 510670, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329876019793736380, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=2., ext=[AuthorCompanyExt(id=1329876019802124989, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019793736380, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.HIMMUC Information Technology (Guangzhou) Co., Ltd., Guangzhou 510670), AuthorCompanyExt(id=1329876019810513598, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019793736380, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.天启黑马信息科技(广州)有限公司,广东 广州 510670)])]), Author(id=1329876020720677587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=47153437@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329876020817146583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020720677587, language=EN, stringName=Lu HUANG, firstName=Lu, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, 5, *, address=3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430072
4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205
5.Guangzhou BioBlue Technology Co., Ltd., Guangzhou 510200, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329876020888449752, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, authorId=1329876020720677587, language=CN, stringName=黄璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, 4, 5, *, address=3.武汉大学药学院,湖北 武汉 430072
4.武汉工程大学化工与制药学院,湖北 武汉 430205
5.广州市丹蓝生物科技有限公司,广东 广州 510200, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329876019881816767, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=3., ext=[AuthorCompanyExt(id=1329876019890205376, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019881816767, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430072), AuthorCompanyExt(id=1329876019894399681, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019881816767, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.武汉大学药学院,湖北 武汉 430072)]), AuthorCompany(id=1329876019948925634, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=4., ext=[AuthorCompanyExt(id=1329876019961508547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019948925634, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205), AuthorCompanyExt(id=1329876019969897156, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876019948925634, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.武汉工程大学化工与制药学院,湖北 武汉 430205)]), AuthorCompany(id=1329876020045394629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, xref=5., ext=[AuthorCompanyExt(id=1329876020053783238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876020045394629, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=5.Guangzhou BioBlue Technology Co., Ltd., Guangzhou 510200), AuthorCompanyExt(id=1329876020066366151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329876018963264182, companyId=1329876020045394629, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=5.广州市丹蓝生物科技有限公司,广东 广州 510200)])])]
赵天1, 李自财2, 黄璐3, 4, 5, *
作者信息
  • 1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663
  • 2.天启黑马信息科技(广州)有限公司,广东 广州 510670
  • 3.武汉大学药学院,湖北 武汉 430072
  • 4.武汉工程大学化工与制药学院,湖北 武汉 430205
  • 5.广州市丹蓝生物科技有限公司,广东 广州 510200
通讯作者:
黄璐(1982—),男,博士,高级工程师,硕士生导师,从事药品与医疗器械开发以及生物医药知识产权工作。E-mail:
作者简介:

赵天(1986—),男,硕士,助理研究员,从事科研管理、知识产权管理以及科技成果转化工作。

Patent Layout and Analysis of Atezolizumab
Tian ZHAO1, Zicai LI2, Lu HUANG3, 4, 5, *
Affiliations
  • 1.Guangdong Provincial Biotechnology Research Institute (Guangdong Provincial Laboratory Animals Monitoring Center), Guangzhou 510663
  • 2.HIMMUC Information Technology (Guangzhou) Co., Ltd., Guangzhou 510670
  • 3.School of Pharmacutical Sciences, Wuhan University, Wuhan 430072
  • 4.School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205
  • 5.Guangzhou BioBlue Technology Co., Ltd., Guangzhou 510200
出版时间: 2024-10-10 doi: 10.16522/j.cnki.cjph.2024.10.006
文章导航
收藏切换

阿替利珠单抗作为一种新的PD-L1抑制剂药物,已成为肿瘤免疫治疗研究的热点之一。文章以阿替利珠单抗为研究对象,利用专利技术分析其相关专利申请状况,并重点从其技术主题和专利布局角度对阿替利珠单抗在中国的专利申请情况进行剖析,从而为国内研究机构和企业进行该药物研发和专利布局策略提供有效的参考和建议。

阿替利珠单抗  /  PD-L1抑制剂  /  肿瘤免疫治疗  /  专利技术分析  /  专利布局

Atezolizumab, as a new PD-L1 inhibitor drug, has become one of the hot spots in tumor immunotherapy research. This review takes atezolizumab as the research object, uses patent technology analysis to study the status of related patent applications, and focuses on the patent applications of atezolizumab in China from the perspective of its technical themes and patent layout, so as to provide some effective references and suggestions for domestic research institutions and enterprises in R&D and patent layout strategies of atezolizumab.

atezolizumab  /  PD-L1 inhibitor  /  tumor immunotherapy  /  patent technology analysis  /  patent layout
赵天, 李自财, 黄璐. 阿替利珠单抗的专利布局及分析. 中国医药工业杂志, 2024 , 55 (10) : 1350 -1358 . DOI: 10.16522/j.cnki.cjph.2024.10.006
Tian ZHAO, Zicai LI, Lu HUANG. Patent Layout and Analysis of Atezolizumab[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (10) : 1350 -1358 . DOI: 10.16522/j.cnki.cjph.2024.10.006
  • 国家社会科学基金项目——“专利到期药物仿制上市法律保障机制研究”(18BFX168)
参考文献 引证文献
排序方式:
[1]
HODI F S, O’DAY S J, MCDERMOTT D F, et al.Improved survival with ipilimumab in patients with metastatic melanoma[J].N Engl J Med, 2010, 363(8): 711-723.
[2]
RIBAS A, WOLCHOK J D.Cancer immunotherapy using checkpoint blockade [J].Science, 2018, 359(6382): 1350-1355.
[3]
YI M, ZHENG X, NIU M, et al.Combination strategies with PD-1/PD-L1 blockade: current advances and future directions[J].Mol Cancer, 2022, 21(1): 28.
[4]
GONG J, LE T Q, MASSARELLI E, et al. Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination [J].J Immunother Cancer, 2018, 6(1): 46.
[5]
FDA.Atezolizumab for urothelial carcinoma [EB/OL].(2016-05-19) [2024-03-01].https://www.fda.gov/drugs/resources-information-approved-drugs/atezolizumab-urothelial-carcinoma.
[6]
INMAN B A, LONGO T A, RAMALINGAM S, et al.Atezolizumab: a PD-L1-blocking antibody for bladder cancer[J].Clin Cancer Res, 2017, 23(8): 1886-1890.
[7]
HERBST R S, GIACCONE G, DE MARINIS F, et al.Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC [J].N Engl J Med, 2020, 383(14): 1328-1339.
[8]
SCHMID P, ADAMS S, RUGO H S, et al.Atezolizumab and Nab-paclitaxel in advanced triple-negative breast cancer [J].N Engl J Med, 2018, 379(22): 2108-2121.
[9]
MITTENDORF E A, ZHANG H, BARRIOS C H, et al.Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer(IMpassion031): a randomised, double-blind, phase 3 trial [J].Lancet, 2020, 396(10257): 1090-1100.
[10]
LEE M S, RYOO B Y, HSU C H, et al.Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma(GO30140): an open-label, multicentre, phase 1b study [J].Lancet Oncol, 2020, 21(6): 808-820.
[11]
刘建,黄璐.中国医药企业知识产权管理[M].北京:知识产权出版社,2021.
[12]
葛凡,孙建,黄璐.小分子周期蛋白依赖性激酶4/6抑制剂药物及其专利研究[J].中国医药工业杂志,2022,53(4):464-473.
[13]
黄璐,钱丽娜,张晓瑜,等.医药领域的专利保护与专利布局策略[J].中国新药杂志,2017,26(2):139-144.
2024年第55卷第10期
26
8
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.10.006
  • 接收时间:2024-01-26
  • 首发时间:2026-11-18
  • 出版时间:2024-10-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-01-26
基金
国家社会科学基金项目——“专利到期药物仿制上市法律保障机制研究”(18BFX168)
作者信息
    1.广东省生物技术研究院(广东省实验动物监测中心),广东 广州 510663
    2.天启黑马信息科技(广州)有限公司,广东 广州 510670
    3.武汉大学药学院,湖北 武汉 430072
    4.武汉工程大学化工与制药学院,湖北 武汉 430205
    5.广州市丹蓝生物科技有限公司,广东 广州 510200

通讯作者:

黄璐(1982—),男,博士,高级工程师,硕士生导师,从事药品与医疗器械开发以及生物医药知识产权工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.10.006
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏